Standard precautions in haemodialysis - the gap between theory and practice

Assessment of combined 24,25 2 3 and 1 a OH 3 therapy PJ. Vitamin 3 and calcium to prevent hip fractures in elderly for bone disease in dialysis patients. Bone 13; 1992: 369–377 women. N Engl J Med 1992; 327: 1637–42 28. Memmos DE, Eastwood JB, Harris E, O’Grady A, de Wardener 37. Standing Committee on the scientific evaluation of dieteary HE. Response of uremic osteoid to vitamin D. Kidney Int 1982; reference intakes: Institute of Medicine. Dietary Intakes: 21 [Suppl ]: S50–S54 Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. 29. Fournier A, Bordier Ph, Gueris J, et al. Comparison of National Academy Press, Washington, DC: 1997 1-alphahydroxycholecalciferol and 25 hydroxycholecalciferol in 38. Jacobus CH, Holick MF, Shao Q, Chen TG, Seely EW. the treatment of renal osteodystrophy: greater effect of 25 Hypervitaminosis D associated with drinking milk. N Engl hydrocholecalciferol on bone mineralization. Kidney Int 1979; J Med 1992; 326: 1173–1177 15: 196–204 39. Fournier A, Said S, Ghazali A, Sechet A, Oprisiu R, Moriniere 30. Halloran BI, Schaeffer P, Lifschitz M, Levens M, Goldsmith Ph. Ostéopathie adynamique de l’urémique: quelle signification RS. Plasma vitamin D metabolite concentration in chronic renal clinique. In: Grünfeld JP ed. Actualités Néphrologiques. failure: effect of oral administration of 25 OH vitamin D. J Clin Flammarion Médecine Sciences, Paris: 1997; 95–128 Endocrinol Metab 1984; 59: 1053–1069 40. Oprisiu R, Bolosiu H, Boca I, Theodoru C, Fournier A, 31. Dusso A, Brown A, Slatopolsky E. Extrarenal production of Heinze V. Renal osteodystrophy during the development stage calcitriol. Semin Nephrol 1994; 14: 144–145 of maintenance dialysis in Transsylvania. Ann Med Intern 1998; 32. Reichel H, Recker A, Deppisch R, Strier E, Ritz E. 25 OH 149: 67–75 vitamin 3 metabolism in vitro by mononuclear cells from 41. Wang M, Hercz G, Sherrard DJ, Segre GV, Pei Y. Relationship hemodialysis patients. Nephron 1992; 62: 404–412 between intact PTH 1-84 parathyroid hormone and bone histo33. Lucas PA, Brown RL, Woodhead JS, Loles GA. 1,25 2 morphometry parameters in dialysis patients without aluminum cholecalciferol and PTH in advanced renal failure: effects of toxicity. Am J Kidney Dis 1995; 26: 836–844 simultaneous protein and phosphorus restriction. Clin Nephrol 42. Hamdy NA, Kanis JA, Beneton MN, et al. Effect of alfacalcidol 1986; 25: 7–10 on natural course of renal bone disease in mild to moderate 34. Lucas PA, Woodhead JS, Brown RC. Vitamin D3 metabolites renal failure. Br Med J 1995; 310: 358–365 in chronic renal failure and after renal transplantation. Nephrol 43. Burke SK, Goldberg DI, Bonventre JV, Slatopolsky EA. Dial Transplant 1988; 3: 70–76 RenagelA a calcium and aluminum free phosphate binder lowers 35. Rutherford WE, Blondin J, Hruska K, Lopelman R, Klahr S,